At diagnosis, CD25, CD26, and ILRAP were commonly expressed on CML LSCs, but were then downregulated in some subpopulations in response to TKI treatment (10). The gene discussed is IL2RA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.